Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential

Cancer Treatment and Research Communications(2024)10.1016/j.ctarc.2025.100864Source: DataRank Database

Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential is a research paper published in Cancer Treatment and Research Communications (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.56)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Yan Xu ORCID,Sean M. Geary ORCID,Yousef Zakharia ORCID,Eman S. Kamel,Youcef M. Rustum ORCID

Live enrichment

PubMed:39813754 PMC:PMC11846624 OpenAlex:https://openalex.org/W4406199434

NCI NIH HHS

Grant: P30 CA086862

NIH

FWCI

0.56

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.ctarc.2025.100864

publisherhttps://doi.org/10.1016/j.ctarc.2025.100864

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39813754

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11846624

repositoryhttps://doaj.org/article/93ee047fa0ac46c788bbba95a2954c8b

Fields of Study

Renal cell carcinoma treatmentRenal and related cancersSelenium in Biological Systems

MeSH Terms

AnimalsCarcinoma, Renal CellFemaleHumansKidney NeoplasmsMaleMethionineMice, NudeSelenomethionineOrganoselenium CompoundsXenograft Model Antitumor AssaysVascular Endothelial Growth Factor ACell Line, TumorCell ProliferationMiceTransforming Growth Factor beta1B7-H1 Antigen

Keywords

Cancer researchRenal cell carcinomaTransforming growth factorCell growthMedicineCellClear cell renal cell carcinomaGrowth factorMethionineInternal medicineOncologyChemistryBiochemistryAmino acidReceptor

Sustainable Development Goals

SDG 0: Zero hungerSDG 0: Good health and well-being

Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential

FAIR Checklist

Authors (7)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)